• 液垂れを低減する点眼ノズルの形状の開発

    藤本 高志、山口 正純、大久保 宏哉、高見 勇人

    あたらしい眼科 40(12):1611~1616,2023©

  • アジマイシン点眼液1%の小児の結膜炎を対象とした特定使用成績調査

    山際 智充、坂本 祐一郎、末信 敏秀

    あたらしい眼科 40(11):1469~1475,2023©

  • Survey of toxicity study packages and designs of intravitreal drugs approved in Japan

    Kotaro Yamada, Yoshinori Yamagiwa, Yu Haranosono

    Fundamental Toxicological Sciences. 2023; 10(6): 249-258.

  • Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis

    Eriko Kunikane1, Yusuke Orii2, Akiko Inoue1, Masaru Inatani2

    1 Senju Pharmaceutical Co., Ltd.

    2 University of Fukui

    Ophthalmol Ther (2023). https://doi.org/10.1007/s40123-023-00794-x

  • New Candidate Preservative in Ophthalmic Solution Instead of Benzalkonium Chloride: 1,3-Didecyl-2-methyl Imidazolium Chloride

    Takuya Iwasaki, Ryosuke Uchiyama, and Kazuto Nosaka

    Chemical and Pharmaceutical Bulletin 71(7) 552–557, 2023

  • Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study

    Yusuke Orii1, Eriko Kunikane2, Yutaka Yamada1, Masakazu Morioka1, Kentaro Iwasaki1, Shogo Arimura1,Akemi Mizuno2 and Masaru Inatani1

    1 Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan

    2 Senju Pharmaceutical Co., Ltd., Osaka 541-0048, Japan

    J. Clin. Med. 2023, 12, 4175. https://doi.org/10.3390/jcm12134175

  • A survey of on the use of genotoxicity and carcinogenicity testing packages for ophthalmic drug development

    Haruna Tahara,Yu Haranosono

    Fundamental Toxicological Sciences. 2023; 10(3): 105-112.

  • Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

    Yasuo Yanagi1, Kanji Takahashi2, Tomohiro Iida3, Fumi Gomi4, Junko Morii5, Eriko Kunikane6, Taiji Sakamoto7

    1 Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan.

    2 Department of Ophthalmology, Kansai Medical University, Osaka, Japan.

    3 Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan.

    4 Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan.

    5 IQVIA Solutions Japan, K.K., Tokyo, Japan.

    6 Senju Pharmaceutical Co., Ltd., Osaka, Japan.

    7 Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

    Ophthalmology and Therapy. 2023. doi:10.1007/s40123-023-00715-y.

  • 点眼剤の製剤設計とそのポイント

    山口正純

    製剤の達人による製剤技術の伝承 製剤設計・製造技術 BASIC&FRONTIER, 429-442

  • 薬物ナノ結晶製剤の眼内動態評価と眼疾患治療への応用性

    増田 柊也1、長井 紀章2

    1近畿大学薬学部(千寿製薬株式会社)

    2近畿大学薬学部

    (株)技術情報協会発刊書籍「新規モダリティ医薬品のための新しいDDS技術と製剤化」

もっと見る